Point72 (Difc) LTD Cytokinetics Inc Transaction History
Point72 (Difc) LTD
- $2.44 Trillion
- Q1 2025
A detailed history of Point72 (Difc) LTD transactions in Cytokinetics Inc stock. As of the latest transaction made, Point72 (Difc) LTD holds 11,515 shares of CYTK stock, worth $369,401. This represents 0.02% of its overall portfolio holdings.
Number of Shares
11,515
Previous 14,958
23.02%
Holding current value
$369,401
Previous $704 Million
34.22%
% of portfolio
0.02%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding CYTK
# of Institutions
408Shares Held
127MCall Options Held
3.66MPut Options Held
900K-
Black Rock Inc. New York, NY14.7MShares$471 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$380 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$319 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$256 Million0.06% of portfolio
-
State Street Corp Boston, MA6.09MShares$195 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.02B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...